Free Trial
→ $100 Trillion “AI Metal” Found in American Ghost Town (From Brownstone Research) (Ad)tc pixel

China SXT Pharmaceuticals (NASDAQ:SXTC) Shares Down 5.7% - Time to Sell?

Written by MarketBeat
Updated August 30, 2025
China SXT Pharmaceuticals logo with Medical background

Key Points

  • China SXT Pharmaceuticals shares fell by 5.7% on Monday, reaching a low of $1.46 before closing at $1.48, reflecting a decline in trading volume by 6% compared to average levels.
  • Wall Street analysts upgraded the stock from a "sell" to a "hold" rating, indicating a potential stabilization in investor sentiment.
  • The company maintains a low debt-to-equity ratio of 0.01 and is actively involved in the research and sale of traditional Chinese medicine products.
  • Five stocks we like better than China SXT Pharmaceuticals.

China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC - Get Free Report) fell 5.7% during mid-day trading on Monday . The stock traded as low as $1.46 and last traded at $1.48. 36,926 shares were traded during mid-day trading, a decline of 6% from the average session volume of 39,235 shares. The stock had previously closed at $1.57.

Analysts Set New Price Targets

Separately, Wall Street Zen upgraded shares of China SXT Pharmaceuticals from a "sell" rating to a "hold" rating in a research report on Saturday, August 2nd.

Get Our Latest Research Report on China SXT Pharmaceuticals

China SXT Pharmaceuticals Stock Performance

The company has a current ratio of 3.54, a quick ratio of 3.40 and a debt-to-equity ratio of 0.01. The stock's 50-day moving average is $1.64 and its two-hundred day moving average is $2.19.

China SXT Pharmaceuticals Company Profile

(Get Free Report)

China SXT Pharmaceuticals, Inc, a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.

Featured Stories

Should You Invest $1,000 in China SXT Pharmaceuticals Right Now?

Before you consider China SXT Pharmaceuticals, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and China SXT Pharmaceuticals wasn't on the list.

While China SXT Pharmaceuticals currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover
7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.